Radient Pharmaceuticals Corporation
(Other OTC/NBB : RXPC)

( )
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Health Technology » Medical Specialties

Company Profile

Radient Pharmaceuticals Corp. engages in the research, development, manufacturing, sale and marketing of its Onko-Sure test kit, a proprietary in-vitro diagnostic cancer test. It enables physicians and their patients to detect and/or monitor the treatment/recurrence of solid tumors by measuring the accumulation of specific breakdown products in the blood called Fibrin and Fibrinogen Degradation products. Onko-Sure is a simple, non-invasive blood test designed to be used for the detection and/or monitoring of cancers, including lung, breast, tongue, stomach, liver, colon, rectal, bladder, brain, hematological, prostate, ovarian, esophageal, cervical, uterine, liver, trophoblastic, thyroid, malignant lymphoma, and pancreatic cancers. The company was founded in 1987 and is headquartered in Tustin, CA.